US Court of Appeals reverses District Court ’s ruling on Aloxi patent

A panel of the United States Court of Appeals for the Federal Circuit has reversed the opinion of the District Court for the District of New Jersey for Aloxi (palonosetron hydrochloride) injection.

Source: Pharmaceutical Technology - May 2, 2017 Category: Pharmaceuticals Source Type: news